In an opinion piece for USA Today, musician and actress Barbra Streisand noted inequalities for women in heart disease research and treatment—resulting in more deaths from cardiovascular disease.

Patients who suffer minor ischemic stroke or a transient ischemic attack (TIA) can lower the risk for a major stroke within 90 days by taking both clopidogrel and aspirin, according to a study published online May 16 in The New England Journal of Medicine.

Children who experienced partial readmission of new-onset type 1 diabetes had significantly lower total cholesterol levels and LDL cholesterol levels compared with non-remitters four to five years after diagnosis, according to a single-center study published May 16 in PLOS One.

Saphenous vein graft (SVG) lesions can be treated just as well with bare metal stents (BMS) as drug-eluting stents (DES), suggests a double-blind, randomized trial published May 11 in The Lancet.

Haider Warraich, MD, used the recently presented CABANA trial to launch into an opinion piece about the medical community’s eagerness to embrace new technologies and invasive procedures.

Researchers from the University of California Los Angeles (UCLA) have developed a new algorithm which better predicts pre- and post-heart transplant survival than existing methods.

One-fourth of transvenous implantable cardioverter defibrillator (ICD) leads has a mechanical complication within 10 years, according to an insurance database analysis published May 10 in the Journal of the American Heart Association.

Left radial access (LRA) for percutaneous coronary intervention (PCI) remains rare in the United Kingdom, according to a registry analysis—but it is associated with similar clinical outcomes as right radial access (RRA) and possibly a reduced risk of stroke.

Patients with stroke-related intracerebral hemorrhage (TICH-2) may benefit from receiving tranexamic acid (TXA), a drug treatment used to treat blood loss from trauma and bleeding after child birth, according to research presented May 16 at the European Stroke Conference in Sweden.

The National Institutes of Health (NIH) has halted enrollment in a $100 million, 10-year study of moderate alcohol intake and its effect on cardiovascular health amid concerns over conflicts of interest with the beverage industry.